Overview
Delve into the tranformative journey from the National Precision Medicine (NPM) datasets to the development of a customised genetic test to screen for common severe recessive diseases among Singaporeans. Witness first-hand how its implementation can potentially make a tangible difference to patient care and outcomes.
Delve into the tranformative journey from the National Precision Medicine (NPM) datasets to the development of a customised genetic test to screen for common severe recessive diseases among Singaporeans. Witness first-hand how its implementation can potentially make a tangible difference to patient care and outcomes. The event will also mark a strategic partnership between Precision Health Research, Singapore (PRECISE) and Diagnostics Development Hub (DxD Hub), a national platform hosted by A*STAR. This partnership is dedicated to productising diagnostics based on data insights and discoveries from the Singapore National Precision Medicine (NPM) programme. This session also serves as an industry networking and engagement opportunity, bringing together Innovation and Enterprise (I&E) units and industry partners within the diagnostics and medtech sectors.
Schedule
Date: 26 Feb 2024, Monday
Time: 2:00 PM - 4:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: 32 Carpenter Street, 059911
Speakers
Speaker's Profile:
Professor Patrick Tan, Executive Director, Precision Health Research, Singapore (PRECISE)
Speaker's Profile:
Dr Saumya Shekhar Jamuar, Senior Consultant, Genetics Services, KK Women’s and Children’s Hospital
Speaker's Profile:
Dr Weng Ruifen, Deputy Chief Executive, Diagnostics Development Hub (DxD Hub)
Speaker's Profile:
A/Prof Danny Soon, Chief Executive Officer, Consortium for Clinical Research and Innovation, Singapore
Moderator's Profile:
Dr Lim Jui, Chief Executive Officer, SGInnovate
